Press Releases

GlobeNewswire, Inc.

REDWOOD CITY, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Liftoff Mobile, Inc. (“Liftoff”) (NASDAQ: LFTO), a global leader in performance marketing and monetization solutions for the app economy, today announced financial results for the quarter...

GlobeNewswire, Inc.

FLOWER MOUND, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results...

GlobeNewswire, Inc.

– Completed enrollment in Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD – – Expect to report topline results from both Phase 2 Seabreeze STAT studies in September 2026 – – Cash runway expected for a period of at least...

GlobeNewswire, Inc.

On track for September 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome (HLHS), a rare pediatric disease and orphan-designated indication...

GlobeNewswire, Inc.

IND for ribupatide oral active with U.S. FDA, initiation of global Phase 3 obesity trials planned for the first half of 2027 Ribupatide injection Phase 2b high-dose trial in obesity fully enrolled, data anticipated in mid-2027 Expanded executive...

GlobeNewswire, Inc.

Entered an exclusive license agreement with Innovent Biologics for SP001, a Phase 2-ready, third-generation anti-CD40L antibody for immune-mediated diseases U.S. Food and Drug Administration approved Utebzi™ (tebipenem pivoxil), the first and only...

GlobeNewswire, Inc.

Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected 2H 2026 ARR-217, a CDH17 targeted ADC for gastrointestinal malignancies, advanced to Phase 1b dose optimization Dosing of first...

GlobeNewswire, Inc.

ALG-170675 has been optimized for both HBsAg RNA inhibition and immuno-activation Single and multiple ascending doses planned Study will allow rapid advancement into participants with chronic HBV infection in Q4 2026 SOUTH SAN FRANCISCO, Calif.,...

GlobeNewswire, Inc.

Singapore, SINGAPORE, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The inaugural Asia Economics and Policy Forum (AEPF2026) successfully concluded in Singapore on 28–29 July 2026, marking an important new platform for international research exchange in...

EIN Presswire

Stimuli-responsive and biomimetic nanomedicines designed to cross the blood–brain barrier may represent the next frontier in glioblastoma treatment CHINA, August 12, 2026 /⁨EINPresswire.com⁩/ -- The inability of most therapies to penetrate the...

EIN Presswire

SHANGHAI, CHINA, August 12, 2026 /⁨EINPresswire.com⁩/ -- As China’s electric vehicle industry moves from rapid domestic expansion toward global growth, success overseas will increasingly depend on more than competitive vehicles.

EIN Presswire

XI'AN, SHAANXI, CHINA, August 12, 2026 /⁨EINPresswire.com⁩/ -- Sourcing spirulina for international markets involves far more than color or a basic nutrition label.

GlobeNewswire, Inc.

Collaboration builds on RYET's Saudi platform to accelerate AI education, technology localization and venture development across the Kingdom KUALA LUMPUR, Malaysia, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET)...

GlobeNewswire, Inc.

BALLERUP, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results...

EIN Presswire

SHENZHEN, GUANGDONG, CHINA, August 12, 2026 /⁨EINPresswire.com⁩/ -- How can a retail brand reduce transit damage while maintaining a premium, retail-ready shelf appearance?

GlobeNewswire, Inc.

Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established Data reported at AACR from...

GlobeNewswire, Inc.

Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Advancing IND-enabling studies for potential first-in-class multi-specific, masked T cell engager programs targeting CLDN18.2 and...

GlobeNewswire, Inc.

Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST® (etripamil) nasal spray Phase 3 registrational trial of etripamil for atrial fibrillation with rapid ventricular...

EIN Presswire

Chinese geomembrane manufacturers support mining, aquaculture, water containment, and environmental projects.

EIN Presswire

YANTAI, SHANDONG, CHINA, August 12, 2026 /⁨EINPresswire.com⁩/ -- The beverage packaging industry in 2026 has transitioned from a focus on mere containment to a sophisticated pursuit of consumer engagement and sensory experience.